N/A
N=25
An Investigation of Ostomy Devices
Ileostomy
Bottom Line
View on ClinicalTrials.gov: NCT01514136 ↗Enrolled (actual)
25
Serious AEs
0.5%
Results posted
Jan 2015
Primary outcome: Primary: Degree of Leakage — 4.2; 4.3; 4.4; 4.3 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ostomy appliance: convex 1-piece drainable (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Coloplast A/S
- Primary completion
- Dec 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Degree of Leakage |
4.2; 4.3; 4.4; 4.3; 3.4; 2.9 | — |
Summary
Coloplast A/S has developed a new ostomy device in 8 versions.
The primary objective of this investigation is to assess and compare the degree of leakage when using the 8 different devices.
The secondary objective is to investigate several performance and safety parameters of the various devices.
The aim of the primary and secondary objectives is to acquire more knowledge about the performance of the newly developed device and inspiration for their further development, if needed.
Given that the investigation is exploratory, pass/fail criteria are not relevant. The investigation result will provide knowledge useful for continued decision-making/device development.
The investigation is designed as a non-blinded, controlled, exploratory investigation that includes a total of 30-40 Danish ileostomy users.
Each subject will test a maximum of 4 convex devices in two rounds of each 4 weeks. Each device will be tested for 7 (± 2) days.
Eligibility Criteria
Inclusion Criteria
- Be at least 18 years old
- Have signed the declaration of informed consent
- Have an ileostomy in a concave area
- Have had an ileostomy for at least three months
- Have used convex plates (for convex users) or flat plates (for flat plate users) for the last month
- Be users of 1-piece or 2-piece open ostomy devices
- Have an ileostomy with a diameter of less than 33 mm
Exclusion Criteria
- Are pregnant or breast-feeding
- Have a double-loop ileostomy
- Have known hypersensitivity or allergy to the devices' component ingredients
- Are receiving/have received radiation treatment and/or chemotherapy within the last 3 months.
- Are receiving/have received local peristomal or systemic steroid treatment within the last month
- Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)
Data sourced from ClinicalTrials.gov (NCT01514136). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.